Wenjin Yin

2.2k citations
90 papers · 1.6k indexed · h-index 23
Topics
Breast Cancer Treatment Studies (25 papers)HER2/EGFR in Cancer Research (20 papers)Cancer-related molecular mechanisms research (12 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONECancer Research

In The Last Decade

Wenjin Yin

82 papers receiving 1.6k citations

Peers

Wenjin Yin
Comparison fields: 5 of 103
  • Molecular Biology 781
  • Cancer Research 739
  • Oncology 647
  • Pulmonary and Respiratory Medicine 314
  • Genetics 162
Replace Angel Rodriguez with:
Angel Rodriguez United States
Davendra Segara Australia
Michaela J. Higgins United States
Jinsong Lu China
Dayong Zheng China
Bisrat G. Debeb United States
Aranzazu Fernández-Martínez Spain
Mirosław Kozłowski Poland
Zhimin Shao China
Johann Zimmermann Switzerland
Wenjin Yin relative to Angel Rodriguez United States Angel Rodriguez's profile →
Citations per field
00.5×1.6×
Angel Rodriguez · 1×
Citations per year

Countries citing papers authored by Wenjin Yin

Since Specialization
Citations

This map shows the geographic impact of Wenjin Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjin Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjin Yin more than expected).

Fields of papers citing papers by Wenjin Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjin Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjin Yin. The network helps show where Wenjin Yin may publish in the future.

Co-authorship network of co-authors of Wenjin Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjin Yin. A scholar is included among the top collaborators of Wenjin Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjin Yin. Wenjin Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 1
5 0
6 6
7 9
8 3
9 6
10 8
11 6
12 2
13 35
14 2
15 18
16 16
17 4
18 18
19 16
20 120

About Wenjin Yin

Wenjin Yin is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 90 papers that have together received 1.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (25 papers), HER2/EGFR in Cancer Research (20 papers) and Cancer-related molecular mechanisms research (12 papers). The work is most often cited by research in Cancer Research (739 citations), Oncology (647 citations) and Molecular Biology (781 citations). Wenjin Yin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jinsong Lu, Liheng Zhou, Yueyao Du, Yanping Lin, Yiwei Jiang, Zhenzhou Shen, Yaohui Wang, Jiong Wu, Shuguang Xu and Gen‐Hong Di. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026